AstraZeneca withdraws COVID-19 vaccine, cites surplus of available updated vaccines
New Delhi: UK-based pharmaceutical major AstraZeneca has started global withdrawal of its COVID-19 vaccine, which was provided in India as 'Covishield' in partnership with Serum Institute of India, days after it admitted to rare side effects of blood clotting and low platelet counts. The withdrawal...